Skip to main content
. Author manuscript; available in PMC: 2014 Jul 3.
Published in final edited form as: Bone Marrow Transplant. 2010 Jun 28;46(4):510–515. doi: 10.1038/bmt.2010.160

Table 1.

Patient characteristics

Characteristics Number of
patients (%)
Age (year) 61 (45–72)
Sex
 Male 34 (57)
 Female 26 (43)
Durie Salmon
 I 11 (18)
 II 16 (27)
 III 33 (55)
Race
 White 39 (65)
 African American 12 (20)
 Other 9 (15)
Ig Subtype
 Non-secretory 2 (3)
 Light chain only 4 (7)
 IgG 38 (63)
 IgA 15 (25)
 IgD 1 (2)
Light Chain
 Lambda 25 (42)
 Kappa 35 (58)
Disease status
 First remission 41 (68)
 Refractory/relapsed 19 (32)
Cytogenetics
 Normal 45 (75)
 Abnormal 15 (25)
Interval between diagnosis and transplant (months) 7 (2–88)
BM plasmacytosis (% of cells) 8.5 (0–95)
β2 microglobulin level
 >3.5 mg/L 23 (38)
 <3.5 mg/L 37 (62)
Median LDH
 <618 IU/L 38 (63)
 >618 IU/L 22 (37)
Serum creatinine (μmol/L) 80 (53–124)
Serum albumin
 >35 g/L 51 (85)
 <35 g/L 9 (15)
Transplant within 12 months 38 (63)
At least a PR before transplant 41 (68)

Abbreviation: PR = partial response.